BIO-GATE AG.
BIG1.XETRA | Manufacture of medical and dental instruments and supplies
BIO-GATE AG, based in Germany, specializes in the development, production, and marketing of medical devices and products with bioactive surfaces. Their core technology involves coating materials with silver to provide antimicrobial properties, primarily targeting applications in medical technology a...Show More
Better Health for All
20
BIO-GATE AG's core business, HyProtect™ and MicroSilver BG™ technologies, are entirely focused on preventing infections and improving health outcomes. HyProtect™ coatings have demonstrably reduced implant-associated re-infection rates from over 50% to 'extremely low' in human patients (over 170 received implants) and from a typical 15% to less than 1% in over 185,000 animal implants.
1
MicroSilver BG™ also shows antiviral effectiveness against various enveloped viruses, including SARS-CoV-2.
2
The company's products are described as non-cytotoxic and biocompatible, with no evidence of revenue from harmful products.
3
The HyProtect™ technology is projected to offer significant cost savings, reducing hip revision operations from €120,000 (with infection) to €16,000 (conventional), indicating a price-to-cost ratio of 1.15-1.25x if the cost of the coating is a small fraction of the €16,000.
4
The company's focus is strongly on preventative health measures. During the COVID-19 pandemic, the company tested its MicroSilver BG™ products for antiviral effectiveness, but there is no evidence of broader crisis response actions or donations.
5
A randomized, controlled clinical trial with over 200 patients for CE approval of HyProtect™ has received regulatory and ethics committee approvals, indicating ethical conduct.
6
Fair Money & Economic Opportunity
0
No evidence available to assess BIO-GATE AG on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantitative data relevant to the Fair Pay & Worker Respect KPIs (living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage) was found in the provided articles. The Glassdoor review, while offering general ratings, explicitly states that only one review is available, making it difficult to draw meaningful conclusions about the company's practices related to these specific metrics.
1
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence was found in the provided articles for BIO-GATE AG regarding any of the Fair Trade & Ethical Sourcing KPIs. The articles either discuss other companies, general fair trade concepts, or provide a company profile without relevant data for scoring.
Honest & Fair Business
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles consistently state that data on regulatory fines, transparency index, whistleblower policy, financial restatements, audit coverage, ESG controversy, complaint resolution time, board conflict-free percentage, anti-corruption policy, and third-party verification is either unavailable or not applicable.
1
While the company is certified to DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016,
2
this information does not provide a quantifiable percentage of ethical claims independently verified, as required by the rubric for the 'third_party_verification' KPI.
Kind to Animals
0
No specific, concrete evidence was found in the provided articles to assess BIO-GATE AG against any of the 'Kind to Animals' KPIs. Information regarding cruelty-free certifications, alternative testing usage by the company, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audit percentages, cage-free sourcing, animal testing policy, animal testing volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement was not explicitly stated for BIO-GATE AG.
1
No War, No Weapons
0
BIO-GATE AG's core business is focused on medical devices and products with bioactive surfaces, primarily for medical technology and healthcare applications, as well as derma cosmetics, veterinary, and industrial/consumer products.
1
This indicates no exposure to weapons in its operations.
Planet-Friendly Business
0
No evidence available to assess BIO-GATE AG on Planet-Friendly Business.
Respect for Cultures & Communities
0
No sustainability data or specific information relevant to the 'Respect for Cultures & Communities' value was available in the provided articles for BIO-GATE AG.
1
The articles explicitly state a complete absence of sustainability data, including details on partnerships, revenue reinvestment, cultural impact assessments, employment demographics, or grievance mechanisms.
2
Safe & Smart Tech
0
The provided article is a general company description and does not contain any specific, concrete data points or information related to data breaches, AI ethics, cybersecurity investment, privacy certifications, security training, encryption, AI audits, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty programs, privacy by design, security testing, data minimization, regulatory compliance, algorithmic harm remediation, or digital rights advocacy.
1
Therefore, no KPIs can be scored based on the evidence provided.
Zero Waste & Sustainable Products
0
No evidence available to assess BIO-GATE AG on Zero Waste & Sustainable Products.